Literature DB >> 24856117

Chemokines and chemokine receptors: update on utility and challenges for the clinician.

Ishan Roy1, Douglas B Evans2, Michael B Dwinell3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24856117      PMCID： PMC4390364          DOI： 10.1016/j.surg.2014.02.006

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  116 in total

Review 1.  The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer.

Authors:  Hannelien Verbeke; Verbeke Hannelien; Karel Geboes; Geboes Karel; Jo Van Damme; Van Damme Jo; Sofie Struyf; Struyf Sofie
Journal:  Biochim Biophys Acta       Date:  2011-11-04

2.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.

Authors:  T Nagasawa; S Hirota; K Tachibana; N Takakura; S Nishikawa; Y Kitamura; N Yoshida; H Kikutani; T Kishimoto
Journal:  Nature       Date:  1996-08-15       Impact factor: 49.962

Review 3.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

4.  Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.

Authors:  Evangelia Razis; Konstantine T Kalogeras; Vassiliki Kotoula; Anastasia G Eleftheraki; Nikitas Nikitas; Ralf Kronenwett; Eleni Timotheadou; Christos Christodoulou; Dimitrios Pectasides; Helen Gogas; Ralph M Wirtz; Thomas Makatsoris; Dimitrios Bafaloukos; Gerasimos Aravantinos; Despina Televantou; Nicholas Pavlidis; George Fountzilas
Journal:  Clin Breast Cancer       Date:  2012-06       Impact factor: 3.225

Review 5.  Lymphocyte homing and homeostasis.

Authors:  E C Butcher; L J Picker
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

6.  Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs.

Authors:  E R Neptune; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

Authors:  G Simmons; P R Clapham; L Picard; R E Offord; M M Rosenkilde; T W Schwartz; R Buser; T N Wells; A E Proudfoot
Journal:  Science       Date:  1997-04-11       Impact factor: 47.728

8.  Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.

Authors:  Luke J Drury; Joshua J Ziarek; Stéphanie Gravel; Christopher T Veldkamp; Tomonori Takekoshi; Samuel T Hwang; Nikolaus Heveker; Brian F Volkman; Michael B Dwinell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-11       Impact factor: 11.205

9.  Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma.

Authors:  Daniel Baumhoer; Jan Smida; Stephanie Zillmer; Michael Rosemann; Michael J Atkinson; Peter J Nelson; Gernot Jundt; Irene von Luettichau; Michaela Nathrath
Journal:  Mod Pathol       Date:  2011-12-16       Impact factor: 7.842

10.  Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist.

Authors:  A E Proudfoot; C A Power; A J Hoogewerf; M O Montjovent; F Borlat; R E Offord; T N Wells
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157
View more
  28 in total

Review 1.  Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds.

Authors:  Latha Satish
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

2.  Gene expression profiles of HTR8-S/Vneo cells after changes in ABCA1 expression.

Authors:  Chengmao Xie; Xiaohui Cai; Xiaoju Wang; Li Lin; Yan Long; Xin Cui
Journal:  Funct Integr Genomics       Date:  2018-06-21       Impact factor: 3.410

Review 3.  Decoding the chemokine network that links leukocytes with decidual cells and the trophoblast during early implantation.

Authors:  Rosanna Ramhorst; Esteban Grasso; Daniel Paparini; Vanesa Hauk; Lucila Gallino; Guillermina Calo; Daiana Vota; Claudia Pérez Leirós
Journal:  Cell Adh Migr       Date:  2016-02-18       Impact factor: 3.405

4.  Amplification of Salt-Sensitive Hypertension and Kidney Damage by Immune Mechanisms.

Authors:  David L Mattson; John Henry Dasinger; Justine M Abais-Battad
Journal:  Am J Hypertens       Date:  2021-02-18       Impact factor: 2.689

5.  Exploiting agonist biased signaling of chemokines to target cancer.

Authors:  Ishan Roy; Anthony E Getschman; Brian F Volkman; Michael B Dwinell
Journal:  Mol Carcinog       Date:  2016-10-04       Impact factor: 4.784

6.  SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K/AKT pathway.

Authors:  Peng Yang; Gang Wang; Hongjun Huo; Qiang Li; Yan Zhao; Yuanhang Liu
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

7.  SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma.

Authors:  Anyan Liao; Ranran Shi; Yuliang Jiang; Suqing Tian; Panpan Li; Fuxi Song; Yalan Qu; Jinna Li; Haiqin Yun; Xiangshan Yang
Journal:  Mol Neurobiol       Date:  2014-11-25       Impact factor: 5.590

8.  Targeting CXC motif chemokine receptor 4 inhibits the proliferation, migration and angiogenesis of lung cancer cells.

Authors:  Wei He; Tong Yang; Xin-Hua Gong; Ru-Zhai Qin; Xiao-Dong Zhang; Wen-Dan Liu
Journal:  Oncol Lett       Date:  2018-07-04       Impact factor: 2.967

9.  CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense.

Authors:  M Carevic; H Öz; K Fuchs; J Laval; C Schroth; N Frey; A Hector; T Bilich; M Haug; A Schmidt; S E Autenrieth; K Bucher; S Beer-Hammer; A Gaggar; M Kneilling; C Benarafa; J L Gao; P M Murphy; S Schwarz; B Moepps; D Hartl
Journal:  J Innate Immun       Date:  2016-03-08       Impact factor: 7.349

10.  IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB.

Authors:  Susan J Burke; Krisztian Stadler; Danhong Lu; Evanna Gleason; Anna Han; Dallas R Donohoe; Richard C Rogers; Gerlinda E Hermann; Michael D Karlstad; J Jason Collier
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-25       Impact factor: 4.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.